Naphthalene anti-psoriatic agents
AssigneeSyntex (U.S.A.) Inc.
InventorsGordon H. Jones, Michael C. Venuti, John M. Young
Life of this patent
Estimating the term…
Loading patent…
AssigneeSyntex (U.S.A.) Inc.
InventorsGordon H. Jones, Michael C. Venuti, John M. Young
Estimating the term…
Psoriasis in mammals is relieved by topically administering naphthalenes of the formula: ##STR1## wherein: R.sup.1 and R.sup.2 are the same and are lower alkoxy, lower alkylthio, optionally substituted phenoxy or optionally substituted phenylthio, R.sup.3 is lower alkyl, lower alkoxy, or halo and m is 0, 1 or 2 or R.sup.3 is optionally substituted phenyl, optionally substituted phenyl lower alkyl, optionally substituted phenyl lower alkoxy, amino, lower alkylamino, lower dialkylamino, cyano, or S(O).sub.n R wherein R is lower alkyl; optionally substituted phenyl; optionally substituted phenyl lower alkyl; or optionally substituted heterocyclic aryl of three to nine ring atoms containing one or two heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, and the pharmaceutically acceptable acid addition salts thereof; and m is 1 and n is 0, 1 or 2; and W is alkyl of one to seven carbon atoms, optionally substituted phenyl or optionally substituted benzyl.
A composition in a form suitable for topical administration for treating the condition of psoriasis which composition comprises a pharmaceutically acceptable, non-toxic carrier and a psoriasis relieving amount of a compound of the formula ##STR10## wherein:
A method of treating psoriasis in mammals which comprises applying an effective amount of a compound of the formula ##STR12## wherein:
A compound of the formula ##STR13## wherein:
Dependencies are inferred from the claim text.